SAN MATEO, Calif.–(BUSINESS WIRE)– December 27, 2024 — BeiGene, Ltd. (NASDAQ:...
Author - David Miller
Sumitomo Pharma America Announces U.S. FDA Approval of Gemtesa...
MARLBOROUGH, Mass., Dec. 23, 2024 /PRNewswire/ — Sumitomo Pharma America, Inc. (SMPA)...
FDA Approves Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) for...
BOSTON–(BUSINESS WIRE)–Dec. 20, 2024– Vertex Pharmaceuticals Incorporated...
U.S. FDA Approves Pfizer’s Braftovi Combination Regimen as...
NEW YORK–(BUSINESS WIRE) December 20, 2024 — Pfizer Inc. (NYSE: PFE) today announced...
FDA Approves Zepbound (tirzepatide) as the First and Only...
INDIANAPOLIS, Dec. 20, 2024 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced...
Vertex Announces U.S. FDA Approval for Trikafta...
BOSTON–(BUSINESS WIRE)–Dec. 20, 2024– Vertex Pharmaceuticals Incorporated...
FDA Approves Alhemo (concizumab-mtci) to Prevent or Reduce...
PLAINSBORO, N.J., Dec. 20, 2024 /PRNewswire/ — Novo Nordisk announced today that the U.S...
Rhythm Pharmaceuticals Announces FDA Approval of Imcivree...
BOSTON, Dec. 20, 2024 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a...
FDA Approves Tryngolza (olezarsen) to Reduce Triglycerides in...
CARLSBAD, Calif., Dec. 19, 2024 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS)...
FDA Approves Symvess (acellular tissue engineered vessel-tyod)...
DURHAM, N.C., Dec. 19, 2024 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a biotechnology...